New patient platform aims to transform rare disease diagnosis through lived experience
A new initiative from Opalmedica is placing patient voices at the centre of efforts to improve rare disease diagnosis, with the launch of its innovative KLEOS™ platform. The platform is designed to tackle one of the most persistent challenges in rare disease care: the...
NCUK VIRTUAL SUMMIT 2021
FREE, PRACTICAL ADVICE FOR THOSE LIVING WITH NEUROENDOCRINE CANCER NCUK are pleased to announce that the Virtual Patient Summit 2021 will be released, one talk per day, from Sunday 31st October up to and including, World Neuroendocrine Cancer Day on 10th November...
Who we were before a cancer diagnosis
VOICES OF NCUK WHO WE WERE BEFORE A CANCER DIAGNOSIS AND WHO WE ARE NOW – THE FACE IN THE MIRROR Before life changed forever, before in fact everything changed and life was turned upside down, we would look in the mirror and see the people we had always been, going...